In brief, RT expands the repertoire of tumor-associated antigens (TAAs) available in the TME while directly stimulating type I IFN expression by activating cyclic-GAMP synthase (cGAS) and its downstream signaling partner stimulator of interferon genes (STING). Here, STING1 is linked to neoplasm.